{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:52:27Z","timestamp":1777431147455,"version":"3.51.4"},"reference-count":30,"publisher":"SAGE Publications","issue":"2-3","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Asia Pac J Public Health"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>Mother-to-child transmission (MTCT) is a primary source of hepatitis B virus (HBV) infection in endemic regions. The World Health Organization (WHO) aims to reduce HBV seroprevalence among children under five to less than 0.1% by 2030. In Malaysia, the seroprevalence of hepatitis B surface antigen (HBsAg) in children has declined to 0.4%, but additional measures are needed. A pilot study in Sarawak, Malaysia, screened 474 pregnant women for HBsAg. Those with high MTCT risk received tenofovir disoproxil fumarate from 28 weeks of gestation to 12 weeks postpartum. Infants received timely birth-dose HBV vaccine and hepatitis B immunoglobulin (HBIG) where indicated. Among screened women, 1.9% were HBsAg positive, with 55.6% newly diagnosed. No MTCT cases were observed. Risk factors included maternal age over 35 years old household exposure, and sexual transmission risk. These findings demonstrate the feasibility of WHO\u2019s PMTCT strategies in low-resource settings, supporting nationwide expansion in Malaysia.<\/jats:p>","DOI":"10.1177\/10105395251414826","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:28:52Z","timestamp":1768836532000},"page":"152-159","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Feasibility and Challenges in Implementing Mother-To-Child Transmission (PMTCT) of Hepatitis B Infection in Resource-Limited Settings in Malaysia"],"prefix":"10.1177","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2379-0487","authenticated-orcid":false,"given":"Puong Sing","family":"Lau","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Sarawak General Hospital, Kuching, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"King Ching","family":"Hii","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Serian Hospital, Serian, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan Sim","family":"Teo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Serian Hospital, Serian, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvin Jung Mau","family":"Chai","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sarawak General Hospital, Kuching, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30579-7"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2003.00487.x"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-008-9050-9"},{"key":"e_1_3_3_5_2","volume-title":"Global Health Sector Strategy on Viral Hepatitis 2016-2021. Towards Ending Viral Hepatitis","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Global Health Sector Strategy on Viral Hepatitis 2016-2021. Towards Ending Viral Hepatitis. World Health Organization; 2016."},{"key":"e_1_3_3_6_2","volume-title":"National Strategic Plan for Hepatitis B and C 2019-2023","author":"Ministry of Health Malaysia; Prevention DC","year":"2019","unstructured":"Ministry of Health Malaysia; Prevention DC. National Strategic Plan for Hepatitis B and C 2019-2023. Ministry of Health Malaysia; 2019."},{"key":"e_1_3_3_7_2","volume-title":"Guidelines for the Prevention, Diagnosis, Care and Treatment for People With Chronic Hepatitis B Infection","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Guidelines for the Prevention, Diagnosis, Care and Treatment for People With Chronic Hepatitis B Infection. World Health Organization; 2024."},{"issue":"2","key":"e_1_3_3_8_2","first-page":"235","article-title":"Prevention of mother-to-child transmission (MTCT) of hepatitis B virus: an observation of routine practice in a tertiary liver centre before and after the introduction of the global health sector strategy on viral hepatitis (GHSSVH)","volume":"78","author":"Hoo CZ","year":"2023","unstructured":"Hoo CZ, Abdullah WZW, Omar H, Tan S-S. Prevention of mother-to-child transmission (MTCT) of hepatitis B virus: an observation of routine practice in a tertiary liver centre before and after the introduction of the global health sector strategy on viral hepatitis (GHSSVH). Med J Malaysia. 2023;78(2):235.","journal-title":"Med J Malaysia"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2022.00047"},{"issue":"3","key":"e_1_3_3_10_2","article-title":"Elimination of perinatal hepatitis B: providing the first vaccine dose within 24 hours of birth","volume":"140","author":"Committee on Infectious Diseases; Committee on Fetus and Newborn","year":"2017","unstructured":"Committee on Infectious Diseases; Committee on Fetus and Newborn. Elimination of perinatal hepatitis B: providing the first vaccine dose within 24 hours of birth. Pediatrics. 2017;140(3):e20171870.","journal-title":"Pediatrics"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-004-0231-4"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piu064"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1508660"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2011.01492.x"},{"key":"e_1_3_3_15_2","volume-title":"Hepatitis Data and Statistics in the Western Pacific. Epidemiological Estimates for Viral Hepatitis in the Western Pacific","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Hepatitis Data and Statistics in the Western Pacific. Epidemiological Estimates for Viral Hepatitis in the Western Pacific. World Health Organization; 2018."},{"issue":"1","key":"e_1_3_3_16_2","first-page":"52","article-title":"Hepatitis in Malaysia: past, present, and future","volume":"6","author":"Raihan R.","year":"2016","unstructured":"Raihan R. Hepatitis in Malaysia: past, present, and future. Euroasian J Hepatogastroenterol. 2016;6(1):52-55.","journal-title":"Euroasian J Hepatogastroenterol"},{"issue":"10","key":"e_1_3_3_17_2","first-page":"800","article-title":"Weighted analysis of prevalence and risk factors of hepatitis B infection among antenatal mothers in Ipoh","volume":"51","author":"Shamsuddin K","year":"2010","unstructured":"Shamsuddin K, Marmuji LZ. Weighted analysis of prevalence and risk factors of hepatitis B infection among antenatal mothers in Ipoh. Singapore Med J. 2010;51(10):800-805.","journal-title":"Singapore Med J"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77813-5"},{"key":"e_1_3_3_19_2","volume-title":"Introducing a Framework for Implementing Triple Elimination of Mother-To-Child Transmission of HIV, Syphilis and Hepatitis B Virus: Policy Brief","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Introducing a Framework for Implementing Triple Elimination of Mother-To-Child Transmission of HIV, Syphilis and Hepatitis B Virus: Policy Brief. World Health Organization; 2024."},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2017.08.001"},{"key":"e_1_3_3_21_2","unstructured":"Ministry of Health Malaysia. Towards elimination of viral hepatitis in Malaysia through multisectoral collaboration 2019. Accessed November 2 2025. https:\/\/www2.moh.gov.my\/moh\/resources\/Penerbitan\/Laporan\/Umum\/CaseStudy-HEPATITIS.pdf"},{"issue":"1","key":"e_1_3_3_22_2","first-page":"113","article-title":"Trends and estimation of hepatitis B infection cases in Malaysia","volume":"16","author":"Rajamoorthy Y","year":"2016","unstructured":"Rajamoorthy Y, Taib N, Rahim K, Munusamy S. Trends and estimation of hepatitis B infection cases in Malaysia. Malaysian J Public Health Med. 2016;16(1):113-120.","journal-title":"Malaysian J Public Health Med"},{"key":"e_1_3_3_23_2","unstructured":"Abon HBsAg Hepatitis B Surface Antigen Rapid Test Device (Whole Blood\/Serum\/Plasma) Product insert. Abbott Laboratories; 2019."},{"key":"e_1_3_3_24_2","volume-title":"Prevention of Mother-To-Child Transmission of Hepatitis B Virus (HBV): Guidelines on Antiviral Prophylaxis in Pregnancy","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Prevention of Mother-To-Child Transmission of Hepatitis B Virus (HBV): Guidelines on Antiviral Prophylaxis in Pregnancy. World Health Organization; 2020."},{"key":"e_1_3_3_25_2","first-page":"19","article-title":"Diagnostic accuracy of tests to detect hepatitis B surface antigen: a systematic review of the literature and meta-analysis","volume":"17","author":"Amini A","year":"2017","unstructured":"Amini A, Varsaneux O, Kelly H, et al. Diagnostic accuracy of tests to detect hepatitis B surface antigen: a systematic review of the literature and meta-analysis. BMC Infect Diss. 2017;17:19-37.","journal-title":"BMC Infect Diss"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1177\/10105395221121047"},{"key":"e_1_3_3_27_2","article-title":"Cost-effectiveness of integrated maternal HIV, syphilis, and hepatitis B screening opt-out strategies in Nepal: a modelling study","volume":"32","author":"Sabin L","year":"2025","unstructured":"Sabin L, Allel K, Gautam G, Saville N, Haghparast-Bidgoli H. Cost-effectiveness of integrated maternal HIV, syphilis, and hepatitis B screening opt-out strategies in Nepal: a modelling study. Lancet Reg Health Southeast Asia. 2025;32:100524.","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","unstructured":"Lim Z Teo J Tan A et al. Prevalence of chronic hepatitis B and C in Malaysia-results from a community-based screening campaign. medRxiv. doi:10.1101\/2020.04.30.20085944","DOI":"10.1101\/2020.04.30.20085944"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/10105395231218056"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.116"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab405"}],"container-title":["Asia Pacific Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10105395251414826","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10105395251414826","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10105395251414826","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:44:20Z","timestamp":1777376660000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10105395251414826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":30,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1177\/10105395251414826"],"URL":"https:\/\/doi.org\/10.1177\/10105395251414826","relation":{},"ISSN":["1010-5395","1941-2479"],"issn-type":[{"value":"1010-5395","type":"print"},{"value":"1941-2479","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]}}}